Management will also quickly add new high-demand products that have been requested by buyers to round out the TapouT Muscle Growth and Recovery line.
In a joint statement by the Managing Members of Beaufort Capital Partners LLC, Leib Schaeffer and Robert Marino announced, "We are honored to be one of the leading investors in Axxess Pharma, Inc. which continues to push the envelope in medical and nutritional products. These products such as their TapouT line, advance the health, comfort and care of those advancing a healthy lifestyle as well as those afflicted by illness and disease. We can think of no greater corporate calling than to partner with exciting companies on the forefront of nutritional health and alleviating pain and discomfort while affording the users with hope and relief."
Daniel Bagi, M.D., President of Axxess Pharma stated: "This is another major milestone for Axxess Pharma. We continue expanding revenue while having funds to fulfill all orders, increase marketing and introduce high-demand products to market. Our TapouT-branded premium products are offered to individuals focussed on improving Quality of Life at every age."